SAN CARLOS, Calif., Feb. 26, 2020 /PRNewswire/ -- Natera, Inc. (NASDAQ:  NTRA), a leader in non-invasive genetic testing and the analysis of circulating cell-free DNA, today reported financial results for the fourth quarter and the year ended December 31, 2019 and provided an update on recent business progress.

RED BANK, N.J., Feb. 26, 2020 /PRNewswire/ -- Actor and comedian Tracy Morgan on Friday presented the "Tracy Morgan Award for Excellence in Rehabilitation Nursing" to a Hackensack Meridian Health JFK Johnson Rehabilitation Institute nurse who has dedicated her 30-year-career to working with brain-i

DUBLIN, Feb. 26, 2020 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the company will webcast its corporate presentations at the following investor conferences:Cowen 40th Annual Healthcare Conference in Boston, MA on Tuesday, March 3, 2020

SAN RAFAEL, Calif., Feb. 26, 2020 /PRNewswire/ --

ROCKVILLE, Md., Feb. 26, 2020 /PRNewswire/ --Additional data from RGX-314 Phase I/IIa trial for wet AMD expected in 1H 2020 RGX-314 clinical trials for treatment of wet AMD and diabetic retinopathy expected to advance in 2020 using subretinal and suprachoroidal delivery approaches Additional interim data from RGX

BALTIMORE, Feb. 26, 2020 PRNewswire/ -- Medifast (NYSE: MED), the company behind one of the fastest-growing health and wellness communities, 

NEW YORK, Feb. 26, 2020 /PRNewswire/ -- Oramed Pharmaceuticals Inc. (NASDAQ: ORMP), (TASE: ORMP), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, today announced that it intends to offer and sell shares of its common stock in an underwritten public offering. All of the shares in the underwritten public offering are to be

CARLSBAD, Calif., Feb. 26, 2020 /PRNewswire/ -- Active Motif Shanghai (a subsidiary of Active Motif, Inc.), in collaboration with Fudan University and its affiliated Public Health Clinical Center, used its single-cell AbEpic™ screening technology to isolate antibodies from patients recovering from 2019 Coronavirus related pneumonia (COVID-19). The samples were

STRASBOURG, France, Feb. 26, 2020 /PRNewswire/ -- Dynacure, a clinical stage drug development company focused on improving the lives of patients with rare and orphan disorders, today announced that the company will be presenting at the 40th Annual Cowen Healthcare Conference being held March 2nd-4th at the Boston Marriott Copley Place hotel.

HOUSTON, Feb. 26, 2020 /PRNewswire/ -- EMIT Corporation announced today that it has been awarded a five-year $20 million maximum contract, effective February 20, 2020, from the Defense Logistics Agency Troop Support, Philadelphia, PA for purchase of its HypothermX®